News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 361–396
- Matches
- 33233
- Sources here
- 14
- Companies here
- 36
Active search
33233 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Applied Optoelectronics SVP Yeh sells $886k in shares
Shu-Hua (Joshua) Yeh, SVP at Applied Optoelectronics (NASDAQ:AAOI), sold 6,000 shares worth $886,379 on August 18, 2026, under a Rule 10b5-1 trading plan. This insider sale follows AAOI's significant stock performance and recent strong Q2 2026 earnings, though future guidance has led to mixed …
Forum Energy Technologies (FET) officer plans seven-figure stock sale
An officer at Forum Energy Technologies (FET), David Lyle Williams, has filed a Rule 144 notice for a proposed sale of 20,068 shares of common stock through Merrill Lynch. The aggregate market value of these shares is approximately $1.57 million. These shares were acquired …
CPS Technologies plans a move to a facility twice its current size
CPS Technologies (NASDAQ:CPSH) has signed a long-term lease for an 80,000-square-foot facility in Attleboro, Massachusetts, which is double the size of its current Norton site. This strategic move aims to support the company's growth, innovation, and expanding customer base by relocating its corporate offices, …
CPS Announces Long-Term Lease for 80,000-Square-Foot Facility in Attleboro, Massachusetts
CPS Technologies Corp. (NASDAQ:CPSH) has signed a long-term lease for an 80,000-square-foot facility in Attleboro, Massachusetts, which is double the size of its current location. This move is a significant investment aimed at supporting future growth, innovation, and an expanding customer base, consolidating all …
Guggenheim initiates coverage on Spruce Biosciences with Buy rating
Guggenheim analyst Debjit Chattopadhyay has initiated coverage on Spruce Biosciences (NASDAQ: SPRB) with a Buy rating and a price target of $123, signaling a positive outlook for the company. This rating indicates Guggenheim's expectation of significant upside from current stock levels, providing a new …
Applied Optoelectronics (NASDAQ: AAOI) exec sells stock under 10b5-1 plan
Yeh Shu-Hua (Joshua), Senior Vice President and Asia General Manager of Applied Optoelectronics (AAOI), sold 6,000 shares of common stock on August 18, 2026. The shares were sold at a weighted average price of $147.73 per share under a pre-arranged Rule 10b5-1 trading plan. …
Cytek Biosciences (CTKB) director now holds 28,499 shares
Cytek Biosciences director Richard Chin converted 6,107 Restricted Stock Units (RSUs) into common stock on August 18, 2026, increasing his direct common stock holdings to 28,499 shares. He still holds 44,790 RSUs, which vest in tranches over three years. This transaction is part of …
Cytek Biosciences (NASDAQ: CTKB) director gains 3,086 no-cost shares
Cytek Biosciences director Glenn P. Muir converted 3,086 Restricted Stock Units (RSUs) into common stock on August 18, 2026, at a price of $0.00 per share. Following this transaction, Muir directly holds 3,086 shares of common stock and an RSU balance of 52,469 units …
James Hardie Plans European Fiber Cement Closure as Holcim Agrees to Buy Fermacell
James Hardie Industries plc announced the strategic divestiture of its European operations, including the sale of its Fermacell business to Holcim for €840 million, and plans to close its European fiber cement business. These actions aim to streamline James Hardie's portfolio, accelerate deleveraging with …
Holcim acquires James Hardie’s European unit for €840 million
Holcim Ltd. is acquiring James Hardie Industries Plc’s European business for nearly €840 million. James Hardie is divesting its European fiber cement business to concentrate on its growth markets in the U.S. and Australia. This acquisition will allow Holcim to expand its offerings in …
Applied Industrial (NYSE: AIT) CFO sells 1,812 shares at $355
Applied Industrial Technologies Inc. (AIT) reported that Vice President-CFO & Treasurer David K. Wells sold 1,812 shares of common stock on August 18, 2026, at a weighted average price of $355.0989 per share. The sale, valued at approximately $643,000, left Wells with 32,050 directly …
Applied Industrial exec exercises 7,700 rights | AIT Insider Trading
Jason W. Vasquez, VP-Sales & Marketing-USSC at Applied Industrial Technologies Inc. (AIT), exercised 7,700 Stock Appreciation Rights on August 18, 2026. The exercise price was $53.87 per share. Following the transaction, 2,774 common shares were withheld to cover exercise costs and tax obligations, and …
L3Harris Technologies Inc. stock outperforms competitors despite losses on the day
Shares of L3Harris Technologies Inc. (LHX) fell 2.41% to $270.44, marking its second consecutive day of losses. Despite this decline, the stock outperformed the broader market, as the S&P 500 Index (SPX) dropped 0.87% and the Dow Jones Industrial Average (DJIA) fell 1.32% on …
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors
Edwards Lifesciences Corp. (EW) shares dropped 2.65% on Thursday, closing at $89.83. This underperformance occurred during a generally negative trading session where the S&P 500 Index and Dow Jones Industrial Average also saw declines. The stock's fall ended a two-day winning streak.
Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing
An insider at Charles River Laboratories International (NYSE: CRL) recently sold shares valued at $599,711, according to a new SEC filing. The company specializes in research and non-clinical drug development, providing services for pharmaceutical companies, government agencies, and academic institutions. This transaction follows other …
Charles River (NYSE: CRL) director exercises options, sells 573 shares
Nancy C. Andrews, a director at Charles River Laboratories (CRL), reported exercising 573 stock options at $164.30 per share and immediately selling the acquired 573 common shares at $285.24 per share. After these transactions, she indirectly holds 3,964 common shares through a trust. The …
Charles River (NYSE: CRL) insider sells 2,039 shares in 10b5-1 plan
Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories (NYSE: CRL), sold 2,039 shares of common stock at $294.12 per share, after exercising stock options at $194.12 per share. This transaction was conducted under a Rule 10b5-1 Trading Plan adopted on …
James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million
Transaction expected to accelerate deleveraging, support return of capital to shareholders, and be accretive to margin profile and ROIC Separately, the Company also intends to close European fiber cement business to enhance focus on core growth regions Actions further align portfolio with Company's long-term …
Sharemaestro market context Trend signal active 52 weeks +43.7% · Next-week setup negative 41.3%Brookfield Infrastructure to Issue $100 Million of Preferred Units
Brookfield Infrastructure Partners LP; Brookfield Infrastructure Corporation All amounts in Canadian dollars NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES The prospectus supplement, the corresponding base shelf prospectus and any amendment thereto in connection with this offering will …
Sharemaestro market context Trend signal active 52 weeks +35.0%Abercrombie & Fitch Co. Announces Election of Mary Fox to its Board of Directors
Abercrombie & Fitch Management Co. Fox brings more than 25 years of experience across consumer products, retail, and omnichannel businesses NEW ALBANY, Ohio, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF), a global, digitally led, omnichannel specialty retailer of apparel …
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott has reached agreements with three law firms to resolve the Gill case and claims involving approximately 2,000 other individuals related to its specialty formulas for preterm infants, totaling about $670 million. The company maintains that its products are safe and necessary, citing medical …
Abbott Will Pay $670 Million to End 2,000 Infant Formula Claims
Abbott Laboratories has agreed to a $670 million settlement to resolve approximately 2,000 lawsuits. These lawsuits alleged that the company's infant formula for premature babies caused necrotizing enterocolitis (NEC), a deadly bowel disease. Abbott maintains it is not admitting liability, and about 1,700 additional …
Rayonier Releases 2025 Corporate Responsibility Report
WILDLIGHT, Fla., August 20, 2026--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) today released its 2025 Corporate Responsibility Report. The report highlights the company's progress across four corporate responsibility pillars: Forests, Planet, People, and Practices. These pillars focus on managing forests sustainably, minimizing environmental impacts, focusing on Team …
Scienture Q2 Revenue Reaches $343,639 as Net Loss Narrows 58%
Scienture Holdings (SCNX) reported a significant increase in Q2 2026 revenue to $343,639, a 510% sequential jump, while narrowing its net loss by 58% to $2.8 million. The company achieved a 97.7% gross margin and launched its second commercial product, REZENOPY. Additionally, institutional investors …
Minerva Neurosciences (NASDAQ: NERV) COO holds 20,872 shares, 750K and 680K options
Minerva Neurosciences' (NASDAQ: NERV) Chief Operating Officer, Joseph H. Reilly, directly owns 20,872 shares of common stock. Additionally, he holds employee stock options for 1,593,725 shares with varying exercise prices and expiration dates, including significant positions of 750,000 shares and 680,000 shares. The report …
NovaBridge Biosciences (NASDAQ: NBP) Share Price, NBP Stock News, NBP Share Price & Updates
This page provides stock price, news, and analysis for NovaBridge Biosciences (NASDAQ: NBP). It includes current trading data, fundamentals like previous close and volume, and links to financial statements, peer comparisons, and research reports. The content is sourced from Unicorn Data Services SAS, trading …